2022 Revenues ($USD) : $3,400,227,604 2022 Revenues (foreign currencies) : JP¥373,481,000,000 2022 R&D spend : $78,022,578 2022 Number of Employees : 25,239 Fiscal Year End : 3/31/2022 Company CEO : Yoshihiko Sano, CEO and president
The Japanese company’s medical device business is especially focused on dialysis and artificial organs. Nipro boasts that it is one of the leading manufacturers of dialyzers in the world. –CN